Related Experiment Videos
Selegiline and mortality in Parkinson's disease
C W Olanow1, S Fahn, J W Langston
1Department of Neurology, Mount Sinai Medical Center, New York, NY 10029, USA.
Annals of Neurology
|December 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.
Movement disorders : official journal of the Movement Disorder Society·2017
Clinical approaches to the development of a neuroprotective therapy for PD.
Experimental neurology·2017
Challenges in Studying Synapses in Alzheimer's Disease.
Annals of neurology·2026
Blood SOD1 Activity in ALS Patients Receiving Tofersen Treatment.
Annals of neurology·2026
A Human Gait Circuit Derived from Brain Lesions and Deep Brain Stimulation.
Annals of neurology·2026
Psychiatric and eye disorders associated with use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs).
Naunyn-Schmiedeberg's archives of pharmacology·2026
Beyond Bayesian integration: how meaning shapes placebo effects.
Trends in neurosciences·2026
Sex-specific cardiometabolic remodeling induced by DPP-4 inhibition under high-fat diet: insights from cardiac proteomics.
Nutrition, metabolism, and cardiovascular diseases : NMCD·2026